From innovation to impact

Two young children, one holding her immunization card, sitting on their father's lap.

2015 milestones

From PATH’s president and board chair

The act of invention is just the beginning

Innovation is sometimes defined as the “eureka moment”—that thunderbolt of discovery and revelation when a new idea or solution takes shape.

At PATH, we know that innovation that changes lives requires ingenuity—and so much more.

Like patience, perseverance, and partnerships. And years of careful, methodical work that paves the way for impact by clearing the obstacles that stand between our brightest ideas and the people who can use them to transform their futures.

We are proud to share with you our latest annual report, including some of the years-in-the-making milestones PATH and our partners celebrated in 2015:

  • The virtual disappearance of deadly meningitis A across large stretches of Africa.

  • Important advances in malaria control and elimination that can hasten the end of the disease, including the first malaria vaccine candidate recommended for pilot use by the World Health Organization.

  • The rollout of a new contraceptive option that reached thousands of African women who had never used modern family planning methods.

  • The launch of a low-cost water treatment product that can produce more than 50 gallons of clean water for schools and communities at the touch of a button.

Over the past five years, PATH and our partners have reached an average of 150 million people per year with lifesaving technologies and approaches like these—innovations that reflect our unwavering commitment to the idea that everyone deserves an equal chance for a healthy life.

Accelerating our impact

With our crosscutting expertise and a global network of more than 2,000 partner organizations, PATH drives health innovation that reaches more people more quickly to improve health and unlock human potential.

Over the past year, we have taken some exciting steps that will accelerate our ability to reach people with transformative health solutions.

PATH launched our new Center for Vaccine Innovation and Access and our Center for Malaria Control and Elimination to make our work even more effective. These centers bring together our multidisciplinary expertise and multiple projects under unified teams of PATH experts. They will work at every step of the complex process of researching, developing, and introducing vaccines and across the spectrum of tools and approaches needed to end malaria for good.

We also joined the global effort to confront emerging health threats such as Zika and Ebola. Working with the US Centers for Disease Control and Prevention and country partners in Senegal, Tanzania, and Vietnam, PATH is helping to strengthen health information systems, laboratory networks, and disease surveillance capacity. These improved systems will equip countries to prevent, detect, and respond to cross-border pandemic threats and public health emergencies.

Thanks to you

Our ability to reach the most vulnerable people with lifesaving innovations—to empower countries and communities to build the foundations of good health—is possible because of you, our partners and supporters. We are profoundly grateful for your support.

Together, we are harnessing the power of innovation to ensure that our collective resolve and “eureka moments” lead to a world where health is within reach for everyone.

Steve Davis signature

Steve Davis
President and CEO

Dean Allen signature

Dean Allen
Chair, Board of Directors

Photo, top: PATH/Aaron Joel Santos

Thank you to our supporters

Collaboration is at the core of our work to improve health and save lives through the power of innovation. We thank the more than 2,400 individual donors, foundations, corporations, and institutions that supported PATH’s work in 2015.

Charity Navigator 4-star charity: 12 years at 4 stars.

Finances

2015 financial summary

Revenue (in thousands)
Foundations$157,504
US government 74,836
Other governments, nongovernmental organizations (NGOs), multilaterals 40,367
Individuals/other 9,960
Investments 4,411
Corporations 1,570
Total revenue $288,648
Expenses (in thousands)
Program-related:
Product development$62,892
Public health50,298
International development24,017
Cross-program initiatives7,817
Program development2,441
Subawards to program partners97,234
Subtotal program-related$244,699
Administrative$36,626
Fundraising3,569
Total expenses$284,894
Assets (in thousands)
Cash and cash equivalents$118,096
Invested grant funds198,894
Contributions and awards receivable278,519
Other24,924
Total assets$620,433
Liabilities and net assets (in thousands)
Total liabilities $48,928
Net assets
Temporarily restricted$546,620
Unrestricted21,495
Permanently restricted3,390
Total net assets $571,505
Total liabilities and net assets$620,433

Leadership

Board of Directors

Executive Team

  • Steve Davis, MA, JD
    President and CEO
  • Amie Batson, MBA
    Chief Strategy Officer
    Vice President, Strategy and Learning
  • Kathy Cahill, MPH
    Vice President, International Development
  • David Fleming, MD
    Vice President, Public Health
  • David C. Kaslow, MD
    Vice President, Product Development
    Director, Center for Vaccine Innovation and Access
  • Dan Laster, JD
    General Counsel
    Vice President, Business and Research Affairs
  • Mark D. Murray
    Vice President, Global Engagement and Communications
  • Kathryn O’Driscoll
    Chief Human Resources Officer
  • Olivia Polius
    Chief Financial Officer
    Vice President, Finance, Technology, and Infrastructure

Program Leaders

International Development

  • Mona Byrkit, MPH
    Mekong Region
  • Kateryna (Katya) Gamazina, MD
    Ukraine
  • Philippe Guinot, MBA
    Senegal
  • Trad Hatton, MA, MHS
    Democratic Republic of the Congo
  • Neeraj Jain, MBA
    India
  • Tirsit Grishaw Legesse, MS
    Ethiopia
  • Zahra Mkomwa, MD, MPH
    Tanzania
  • Nanthalile Mugala, MD, MMed
    Zambia
  • Emmanuel Mugisha, PhD, MPH
    Uganda
  • Rikka Trangsrud, MA
    Kenya
  • To be hired
    South Africa

Product development

  • Deborah Atherly, PhD
    Policy, Access, and Introduction, Center for Vaccine Innovation and Access
  • Ashley Birkett, PhD
    Malaria Vaccine Initiative and Malaria Vaccines, Center for Vaccine Innovation and Access
  • Tala de los Santos, MS, MBA
    Diagnostics
  • John Konz, PhD
    Integrated Portfolio and Financial Management, Center for Vaccine Innovation and Access
  • Jessica Milman, MPH
    Office of Product Development
  • David Shoultz, PhD, MS, MBA
    Devices and Tools
    Drug Development
  • YanXiang (Michael) Wang, MBA
    China

Public health

  • Cyril Engmann, MD, FAAP
    Maternal, Newborn, and Child Health and Nutrition
  • Jane Hutchings, MPH
    Reproductive Health
  • Katharine Kreis, MPH
    Nutrition Innovations
  • Helen McGuire, MHA
    Noncommunicable Diseases
  • Dykki Settle
    Digital Health Solutions
  • Larry Slutsker, MD, MPH
    Malaria and Neglected Tropical Diseases
    Center for Malaria Control and Elimination
  • Johannes van Dam, MD, MSc
    Health Systems Innovation and Delivery
    HIV/AIDS and Tuberculosis

PATH’s global presence

PATH works in more than 70 countries to accelerate innovation that saves lives and improves health, especially among women and children.

Our country-based projects tackle top-priority health challenges at the local and national levels in collaboration with governments, private-sector partners, and others. Our global partnerships address international-level health priorities, policies, and financing in collaboration with policymakers, funders, and others.

World map showing PATH project, partnership, and office locations.
Country-based projects Global partnerships PATH office

Office locations

  • Belgium | Brussels
  • China | Beijing
  • Democratic Republic of the Congo | Bunia, Kinshasa, Kisangani, Lubumbashi
  • Ethiopia | Addis Ababa, Injibara
  • Ghana | Accra
  • India | Bangalore, Lucknow, Mumbai, New Delhi
  • Kenya | Bungoma, Busia, Kakamega, Kisumu, Migori, Nairobi, Nyamira, Oyugis
  • Malawi | Lilongwe
  • Mozambique | Maputo, Matola
  • Myanmar | Yangon
  • Peru | Lima
  • Senegal | Dakar
  • South Africa | Empangeni, Johannesburg, Kuruman, Sedibeng, Witbank
  • Switzerland | Geneva
  • Tanzania | Arusha, Dar es Salaam
  • Uganda | Kampala, Mbarara
  • Ukraine | Kyiv
  • United States | San Francisco, Seattle (headquarters), Washington, DC
  • Vietnam | Hanoi, Ho Chi Minh City
  • Zambia | Livingstone, Lusaka